Non-alcoholic fatty liver is the most common liver disease worldwide. Here, we show that the mitochondrial protein mitofusin 2 (Mfn2) protects against liver disease. Reduced Mfn2 expression was detected in liver biopsies from patients with non-alcoholic steatohepatitis (NASH). Moreover, reduced Mfn2 levels were detected in mouse models of steatosis or NASH, and its re-expression in a NASH mouse model ameliorated the disease. Liver-specific ablation of Mfn2 in mice provoked inflammation, triglyceride accumulation, fibrosis, and liver cancer. We demonstrate that Mfn2 binds phosphatidylserine (PS) and can specifically extract PS into membrane domains, favoring PS transfer to mitochondria and mitochondrial phosphatidylethanolamine (PE) synthesis. Consequently, hepatic Mfn2 deficiency reduces PS transfer and phospholipid synthesis, leading to endoplasmic reticulum (ER) stress and the development of a NASH-like phenotype and liver cancer. Ablation of Mfn2 in liver reveals that disruption of ER-mitochondrial PS transfer is a new mechanism involved in the development of liver disease.
Pubmed ID: 31051106 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This polyclonal targets ATP2A2/SERCA2
View all literature mentionsThis monoclonal targets Ki67
View all literature mentionsThis unknown targets Histone H2A.x / H2AFX
View all literature mentionsThis polyclonal targets P4HB
View all literature mentionsThis monoclonal targets Tim44
View all literature mentionsThis polyclonal targets SAPK/JNK
View all literature mentionsThis monoclonal targets FACL4
View all literature mentionsThis monoclonal targets synthetic phosphopeptide corresponding to residues surrounding Thr183/Tyr185 of human SAPK/JNK
View all literature mentionsThis polyclonal targets Calnexin (H-70)
View all literature mentionsThis monoclonal targets 6X His tag??
View all literature mentionsThis polyclonal targets OPRS1 antibody
View all literature mentionsThis polyclonal targets PEMT antibody
View all literature mentionsThis unknown targets PACS2
View all literature mentionsThis polyclonal targets PTDSS2 (phosphatidylserine synthase 2) (against the N terminal of PTDSS2)(50ug)
View all literature mentionsThis monoclonal targets ATF-6, full-length,cleaved
View all literature mentionsThis polyclonal targets IRE1 (phospho S724)
View all literature mentionsThis recombinant monoclonal targets IRE1-alpha
View all literature mentionsThis polyclonal targets DDIT3
View all literature mentionsThis polyclonal targets PTDSS1 (phosphatidylserine synthase 1) (against the N terminal of PTDSS1) (50ug)
View all literature mentionsThis polyclonal targets eIF2 alpha
View all literature mentionsThis polyclonal targets PERK
View all literature mentionsThis polyclonal targets Phospho-eIF2alpha (Ser51)
View all literature mentionsThis monoclonal targets BiP (C50B12) Rabbit mAb
View all literature mentionsThis monoclonal targets β-Actin
View all literature mentionsThis monoclonal targets Phospho-PERK (Thr980)
View all literature mentionsThis monoclonal targets Mfn2
View all literature mentionsThis monoclonal targets MFN1
View all literature mentionsThis polyclonal targets Cleaved Caspase-3 (Asp175)
View all literature mentionsThis monoclonal targets Red fluorescent protein
View all literature mentionsMus musculus with name STOCK Mfn2tm3Dcc/Mmucd from MMRRC.
View all literature mentions